Mar 30, 2023 / 08:30PM GMT
Operator
Good day, everyone, and welcome to IGM Biosciences Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Today's call is being recorded.
At this time, I would like to turn the call over to Fred Schwarzer, Chief Executive Officer of IGM.
Fred M. Schwarzer - IGM Biosciences, Inc. - CEO, President & Director
Thank you, operator, and thanks to all of you joining us on this call. On behalf of IGM, I'm joined today by Misbah Tahir, Chief Financial Officer; Dr. Chris Takimoto, Chief Medical Officer; Dr. Bruce Keyt, Chief Scientific Officer; and Dr. Mary Beth Harler, President, IGM Autoimmunity and Inflammation.
Please note that we will be making forward-looking statements on this call including statements about IGM's plans, expectations and forecasts and about future events. Actual results may differ materially as a result of various risks and uncertainties including those discussed in the company's most recent annual report on Form 10-K as well as its other filings with the SEC.
Any forward-looking statements
Q4 2022 IGM Biosciences Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
